Completed
Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal Cancer
NCT00116506
- Conditions
- Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +13 more
- Locations
-
- Massachusett General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States